Relative Bioavailability of Linaprazan for the Test Formulation vs. Reference Formulation

Summary

This is a single-center, open-label, randomized, single dose, 3-way crossover study in healthy volunteers designed to evaluate the relative bioavailability of a new oral tablet formulation of linaprazan glurate in comparison to a previously studied oral tablet formulation under fasting conditions, and to assess the effect of a high fat, high calorie meal on the pharmacokinetics (PK) of linaprazan glurate and the active substance linaprazan after the administration of the new oral tablet formulation.

Timeline

Start

2022-11-15

Primary completion

2022-12-30

Completion

2023-01-03

Drugs

Indications

No indication recorded.